CochLear (OTCMKTS:CHEOY – Get Free Report) and SeaStar Medical (NASDAQ:ICU – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.
Analyst Ratings
This is a breakdown of current recommendations for CochLear and SeaStar Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CochLear | 0 | 3 | 1 | 1 | 2.60 |
| SeaStar Medical | 1 | 0 | 1 | 0 | 2.00 |
SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 62.60%. Given SeaStar Medical’s higher possible upside, analysts clearly believe SeaStar Medical is more favorable than CochLear.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CochLear | $1.53 billion | 3.59 | $251.85 million | N/A | N/A |
| SeaStar Medical | $1.23 million | 16.00 | -$12.15 million | ($4.80) | -1.03 |
CochLear has higher revenue and earnings than SeaStar Medical.
Volatility and Risk
CochLear has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the S&P 500.
Insider and Institutional Ownership
1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares CochLear and SeaStar Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CochLear | N/A | N/A | N/A |
| SeaStar Medical | -828.62% | -146.29% | -96.48% |
Summary
CochLear beats SeaStar Medical on 8 of the 12 factors compared between the two stocks.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
